论文部分内容阅读
目的:探讨在小儿毛细支气管炎临床上应用痰热清注射液的临床疗效。方法:随机将2011年11月～2012年11月在我院诊治的133例小儿毛细支气管炎患者随机分为观察组(痰热清+常规治疗组)67例及对照组(常规治疗组)66例,分析治疗效果。结果:比较2组毛细支气管炎小儿患者的临床治疗效果,结果观察组显效率为82.1%,明显高于对照组;比较临床症状及体征缓解时间,结果观察组临床症状缓解时间平均为2.6±1.1天、临床体征缓解平均时间为3.3±1.2天,均明显短于对照组,以上差异明显,P均<0.05;2组并发症发生率均未0.0%,无明显差异性,P>0.05。结论:在常规治疗小儿毛细支气管炎的用药基础上给予中药制剂痰热清注射液能够显著增加治疗效果,同时不明显增加药物副作用,适合临床应用。
Objective: To investigate the clinical efficacy of Tanreqing injection in children with bronchiolitis. Methods: A total of 133 children with bronchiolitis treated in our hospital from November 2011 to November 2012 were randomly divided into observation group (Tanreqing + conventional treatment group) and control group (conventional treatment group). Cases, analysis of treatment. Results: The clinical treatment effect of pediatric patients with bronchiolitis was compared. Results The effective rate in observation group was 82.1%, which was significantly higher than that in control group. The clinical symptom and symptom relief time were compared. Results The average clinical symptom relief time in observation group was 2.6 ± 1.1 Day, the average clinical symptom relief time was 3.3 ± 1.2 days, were significantly shorter than the control group, the above differences were significant, P <0.05; no incidence of complications in the two groups 0.0%, no significant difference, P> 0.05. Conclusion: The conventional treatment of bronchiolitis in children on the basis of medication given Tanreqing injection can significantly increase the therapeutic effect, while not significantly increase drug side effects, suitable for clinical applications.